AbbVie Inc. (ABBV) vs The Coca-Cola Company (KO)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

Founded in 1886 and headquartered in Atlanta, The Coca-Cola Company is the world’s largest nonalcoholic beverage company, with a broad portfolio of 200 brands spanning major categories such as carbonated soft drinks, water, sports drinks, energy drinks, juice, and coffee. Through its bottling operations and distribution partners, Coca-Cola markets finished beverage products under its own and licensed brands via retailers and food-service outlets in more than 200 countries and regions worldwide. Approximately 60% of the company’s total revenue comes from international markets, with significant contributions from emerging economies in Latin America and the Asia-Pacific region.